Advertisement

European Journal of Pediatrics

, Volume 178, Issue 5, pp 771–776 | Cite as

Diverse cutaneous manifestation of Langerhans cell histiocytosis: a 10-year retrospective cohort study

  • Supattarawadee Poompuen
  • Jitjira Chaiyarit
  • Leelawadee TechasatianEmail author
Original Article

Abstract

Cutaneous manifestation is a common presentation of LCH and is usually a leading clue for the disease diagnosis. Having cutaneous lesions did not show a significantly early age onset at diagnosis compared to those without skin lesions, P value = 0.71. In the present study, cutaneous findings were found as 77.7%. Seborrheic dermatitis-like lesions were the most common cutaneous type (42.8%), followed by papules/nodules/masses (28.5%), petechiae/hemorrhagic lesions (17.8%), and eczematous lesions (10.7%). Time to diagnosis of LCH presented with seborrheic dermatitis-like lesions was significantly longer than other cutaneous presentations, P value = 0.0011.

Conclusion: Patients with LCH who had the manifestations of seborrheic dermatitis-like lesions can have diagnosis delayed due to the difficulty in distinguishing these lesions from normal seborrheic dermatitis lesions. Petechiae/hemorrhagic cutaneous signs in addition to the normal seborrheic dermatitis is the clue for early detection of the disease. To improve early detection of LCH, general pediatricians should be alerted to be aware of these skin symptoms, and if they persist, a dermatologist, pediatric if available, should be immediately consulted.

What is Known?

Cutaneous manifestation is a common presentation of LCH and is usually a leading clue for the disease diagnosis.

What is New?

Patients with LCH who have the manifestations of seborrheic dermatitis-like lesions can have a delayed diagnosis due to the difficulty in distinguishing normal from seborrheic dermatitis lesions.

Petechiae/hemorrhagic cutaneous signs in addition to the normal seborrheic dermatitis are the clue to the early disease detection.

Keywords

Langerhans cell histiocytosis LCH Seborrheic dermatitis Petechiae Hemorrhagic lesions 

Abbreviations

LCH

Langerhans cell histiocytosis

S-S LCH

Single-system Langerhans cell histiocytosis

M-S LCH

Multisystem Langerhans cell histiocytosis

Notes

Acknowledgements

We would like to acknowledge Prof. James Arthur Will, for editing the manuscript via publication clinic KKU, Thailand.

Authors’ contribution

L. Techasatian contributed to the conception and design of the study, data analysis, interpretation of findings, drafting the article, revising the article, and final approval of the version submitted. S. Poompuen contributed to study conception and data collection. J. Chaiyarit contributed to data processing and data analysis, critical revision of the article, and final approval of the version submitted.

Compliance with ethical standards

Ethical approval and informed consent

The study was approved by the institutional review board of Faculty of Medicine, Khon Kaen University, Thailand (IRB no. #HE591399), before enrolling any participants.

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Techasatian L, Waraasawapati S (2017) Multiple yellow-red papules on the head and neck in a 3-month-old boy. Pediatr Int Off J Jpn Pediatr Soc 59(1):118–119CrossRefGoogle Scholar
  2. 2.
    Mandel VD, Ferrari C, Cesinaro AM, Pellacani G, Del Forno C (2014) Congenital “self-healing” Langerhans cell histiocytosis (Hashimoto-Pritzker disease): a report of two cases with the same cutaneous manifestations but different clinical course. J Dermatol 41(12):1098–1101CrossRefGoogle Scholar
  3. 3.
    Wollina U, Langner D, Hansel G, Schönlebe J (2016) Cutaneous Langerhans cell histiocytosis: the spectrum of a rare cutaneous neoplasia. Wien Med Wochenschr 1946:5Google Scholar
  4. 4.
    Ng SS-Y, Koh MJ-A, Tay Y-K (2013) Cutaneous Langerhans cell histiocytosis: study of Asian children shows good overall prognosis. Acta Paediatr Oslo Nor 1992 102(11):e514–e518Google Scholar
  5. 5.
    Morren M-A, Vanden Broecke K, Vangeebergen L, Sillevis-Smitt JH, Van Den Berghe P, Hauben E et al (2016) Diverse cutaneous presentations of Langerhans cell histiocytosis in children: a retrospective cohort study. Pediatr Blood Cancer 63(3):486–492CrossRefGoogle Scholar
  6. 6.
    Minkov M, Prosch H, Steiner M, Grois N, Pötschger U, Kaatsch P et al (2005) Langerhans cell histiocytosis in neonates. Pediatr Blood Cancer 45(6):802–807CrossRefGoogle Scholar
  7. 7.
    Flores-Terry MA, Sanz-Trenado JL, García-Arpa M, Cortina-de la Calle MP (2018) Cutaneous Langerhans cell histiocytosis presenting in adulthood. Actas DermosifiliogrGoogle Scholar
  8. 8.
    Allen CE, Merad M, McClain KL (2018) Langerhans-cell histiocytosis. N Engl J Med 379(9):856–868CrossRefGoogle Scholar
  9. 9.
    Tran G, Huynh TN, Paller AS (2018) Langerhans cell histiocytosis: a neoplastic disorder driven by Ras-ERK pathway mutations. J Am Acad Dermatol 78(3):579–590.e4CrossRefGoogle Scholar
  10. 10.
    Chong VC-L, Tan CL, Chee Y-L, De Mel S (2018) A young patient with a lytic skull lesion. J Clin Pathol 26Google Scholar
  11. 11.
    Zhu H, Ma Y, Sun L, Zhang R, Lv L, Wang A (2018) Langerhans cell histiocytosis with lymph node involvment presenting as erythroderma. Acta Derm VenereolGoogle Scholar
  12. 12.
    Stein SL, Paller AS, Haut PR, Mancini AJ (2001) Langerhans cell histiocytosis presenting in the neonatal period: a retrospective case series. Arch Pediatr Adolesc Med 155(7):778–783CrossRefGoogle Scholar
  13. 13.
    El Fekih N, Kamoun I, Jones M, Remmeh S, Zéglaoui F, Ben Slama C et al (2013) Histiocytosis X revealed by diabetes insipidus and skin lesions. Am J Dermatopathol 35(5):606–608CrossRefGoogle Scholar
  14. 14.
    Rigaud C, Barkaoui MA, Thomas C, Bertrand Y, Lambilliotte A, Miron J et al (2016) Langerhans cell histiocytosis: therapeutic strategy and outcome in a 30-year nationwide cohort of 1478 patients under 18 years of age. Br J Haematol 174(6):887–898CrossRefGoogle Scholar
  15. 15.
    Ahuja A, Uppe A, Nair G (2018) Multisystem involvement of Langerhans cell histiocytosis. J Assoc Physicians India 66(4):75–76Google Scholar
  16. 16.
    Favara BE, Feller AC, Pauli M, Jaffe ES, Weiss LM, Arico M et al (1997) Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic/Reticulum Cell Proliferations Reclassification Working Group of the Histiocyte Society. Med Pediatr Oncol 29(3):157–166CrossRefGoogle Scholar
  17. 17.
    Behera B, Malathi M, Thappa DM, Gochhait D, Srinivas BH, Toi PC (2018) Dermoscopic features of three cases of Langerhans cell histiocytosis. Indian J Dermatol Venereol Leprol 84(6):730–735CrossRefGoogle Scholar
  18. 18.
    Krooks J, Minkov M, Weatherall AG (2018) Langerhans cell histiocytosis in children: Diagnosis, differential diagnosis, treatment, sequelae, and standardized follow-up. J Am Acad Dermatol 78(6):1047–1056CrossRefGoogle Scholar
  19. 19.
    Bellinato F, Maurelli M, Colato C, Balter R, Girolomoni G, Schena D (2018) BRAF V600E expression in juvenile xanthogranuloma occurring after Langerhans cell histiocytosis. Br J DermatolGoogle Scholar
  20. 20.
    Varga E, Korom I, Polyánka H, Szabó K, Széll M, Baltás E et al (2015) BRAFV600E mutation in cutaneous lesions of patients with adult Langerhans cell histiocytosis. J Eur Acad Dermatol Venereol 29(6):1205–1211CrossRefGoogle Scholar
  21. 21.
    Rizzo FM, Cives M, Simone V, Silvestris F (2014) New insights into the molecular pathogenesis of langerhans cell histiocytosis. Oncologist 19(2):151–163CrossRefGoogle Scholar
  22. 22.
    Chan MMH, Tan DJA, Koh MJ-A, Tan LS (2018) Blistering Langerhans cell histiocytosis. Lancet Oncol 19(9):e500CrossRefGoogle Scholar
  23. 23.
    Dodd E, Hook K (2016) Topical Imiquimod for the treatment of childhood cutaneous Langerhans cell histiocytosis. Pediatr Dermatol 33(3):e184–e185CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Dermatology Division, Department of Pediatrics, Faculty of MedicineKhon Kaen UniversityKhon KaenThailand
  2. 2.Clinical Epidemiology Unit, Faculty of MedicineKhon Kaen UniversityKhon KaenThailand

Personalised recommendations